Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,177Revenue (TTM) $M748Net Margin (%)13.0Altman Z-Score2.2
Enterprise Value $M1,228EPS (TTM) $1.3Operating Margin %17.3Piotroski F-Score7
P/E(ttm)13.0Beneish M-Score-3.0Pre-tax Margin (%)17.3Higher ROA y-yY
Price/Book1.610-y EBITDA Growth Rate %--Quick Ratio1.0Cash flow > EarningsY
Price/Sales1.75-y EBITDA Growth Rate %6.2Current Ratio1.2Lower Leverage y-yY
Price/Free Cash Flow9.9y-y EBITDA Growth Rate %-9.5ROA % (ttm)10.4Higher Current Ratio y-yN
Dividend Yield %--PEG2.1ROE % (ttm)13.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M68.4ROIC % (ttm)15.8Gross Margin Increase y-yN

Gurus Latest Trades with MYGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYGNFirst Eagle Investment 2016-09-30 Sold Out -0.03%$19.7 - $32.49
($25.36)
$ 16.99-33%Sold Out0
MYGNJoel Greenblatt 2016-09-30 Add0.02%$19.7 - $32.49
($25.36)
$ 16.99-33%Add 16.88%421,728
MYGNMario Gabelli 2016-09-30 Sold Out -0.01%$19.7 - $32.49
($25.36)
$ 16.99-33%Sold Out0
MYGNRon Baron 2016-09-30 Buy $19.7 - $32.49
($25.36)
$ 16.99-33%New holding40,000
MYGNKen Fisher 2016-09-30 Add$19.7 - $32.49
($25.36)
$ 16.99-33%Add 0.16%92,381
MYGNJoel Greenblatt 2016-06-30 Add0.06%$29.12 - $39.5
($34.78)
$ 16.99-51%Add 79.05%360,830
MYGNFirst Eagle Investment 2016-06-30 Buy 0.03%$29.12 - $39.5
($34.78)
$ 16.99-51%New holding368,980
MYGNKen Fisher 2016-06-30 Add$29.12 - $39.5
($34.78)
$ 16.99-51%Add 2.73%92,236
MYGNJoel Greenblatt 2016-03-31 Add$34.12 - $43.16
($37.75)
$ 16.99-55%Add 2.63%201,527
MYGNKen Fisher 2016-03-31 Add$34.12 - $43.16
($37.75)
$ 16.99-55%Add 0.01%89,783
MYGNJoel Greenblatt 2015-12-31 Buy 0.09%$37.77 - $46.16
($42.36)
$ 16.99-60%New holding196,364
MYGNKen Fisher 2015-09-30 Add$30.94 - $41.39
($35.43)
$ 16.99-52%Add 1.96%89,775
MYGNJoel Greenblatt 2015-03-31 Sold Out -0.16%$32.63 - $39.49
($35.79)
$ 16.99-53%Sold Out0
MYGNMario Gabelli 2015-03-31 Buy $32.63 - $39.49
($35.79)
$ 16.99-53%New holding25,000
MYGNKen Fisher 2015-03-31 Reduce$32.63 - $39.49
($35.79)
$ 16.99-53%Reduce -0.32%88,050
MYGNJoel Greenblatt 2014-12-31 Reduce-0.11%$32.01 - $39.49
($35.44)
$ 16.99-52%Reduce -34.58%568,865
MYGNKen Fisher 2014-12-31 Buy 0.01%$32.01 - $39.48
($35.39)
$ 16.99-52%New holding88,333
MYGNJoel Greenblatt 2014-09-30 Reduce-0.12%$35.44 - $40.41
($37.28)
$ 16.99-54%Reduce -22.18%869,531
MYGNFirst Eagle Investment 2014-06-30 Sold Out -0.026%$33.1 - $42.21
($37.11)
$ 16.99-54%Sold Out0
MYGNThird Avenue Management 2014-03-31 Sold Out -0.13%$20.79 - $38.17
($30.6)
$ 16.99-44%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MYGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HENDERSON JOHN TDirector 2016-09-12Sell30,000$20.49-17.08view
Capone Mark ChristopherPresident & C.E.O. 2016-08-19Buy10,000$21.24-20.01view
McDade Ralph LPresident Myriad RBM, Inc. 2016-08-12Buy1,000$21.49-20.94view
Ford AlexanderPresident, MGL 2016-06-21Sell18,637$30.87-44.96view
King Gary A.Exec. VP International Ops 2016-04-06Sell15,000$39.03-56.47view
King Gary A.Exec. VP International Ops 2016-04-01Sell15,000$38.12-55.43view
GILBERT WALTER PHDDirector 2015-12-11Sell5,000$42.23-59.77view
Phanstiel S. LouiseDirector 2015-12-08Sell5,000$44-61.39view
DREISMANN HEINRICHDirector 2015-11-05Sell60,000$44.44-61.77view
MARSH RICHARD ME.V.P., General Counsel 2015-11-04Sell35,000$44.5-61.82view

Quarterly/Annual Reports about MYGN:

News about MYGN:

Articles On GuruFocus.com
Chuck Royce Reduces Several Positions in 4th Quarter Feb 05 2016 
Chuck Royce Comments on Myriad Genetics Oct 08 2014 
Chuck Royce’s Royce Premier Fund Second Quarter 2014 Manager Commentary Oct 08 2014 
Why I Bought Myriad Genetics (MYGN) Apr 28 2014 
Scott Black, Delphi Management Recommends Stocks Nov 19 2013 
Surfing for Billionaire Bargains Sep 22 2013 
Baron Funds Comments on Myriad Genetics Inc. Jun 06 2013 
RS Investments' Value Fund First Quarter 2012 Mutual Fund Commentary Apr 17 2012 
Chuck Royce Buys Hawkins Inc., Myriad Genetics, and Fairchild Semiconductor Jul 07 2011 
Myriad Genetics Inc. Reports Operating Results (10-Q) May 05 2010 

More From Other Websites
7:06 am Myriad Genetics announces results of a study comparing the efficacy of six tests used to... Dec 09 2016
The EndoPredict® Test Significantly Outperforms the First-Generation Test in Predicting the Risk of... Dec 09 2016
MYRIAD GENETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Dec 02 2016
Has the Smart Money Unearthed a Hidden Gem in Myriad Genetics, Inc. (MYGN)? Dec 01 2016
Myriad Genetics Will Present Results from Six Breast Cancer Studies at SABCS Nov 28 2016
How This Fund’s Investments in NorthStar Asset Management (NSAM), CONMED Corporation (CNMD) &... Nov 18 2016
MYRIAD GENETICS INC Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets,... Nov 14 2016
Crescendo Bioscience Announces Four Studies with Vectra® DA Will Be Presented at the American... Nov 12 2016
MYRIAD GENETICS INC Financials Nov 09 2016
Myriad Will Seek Japanese Regulatory Approval for BRACAnalysis CDx® Nov 07 2016
Myriad Will Seek Japanese Regulatory Approval for BRACAnalysis CDx® Nov 07 2016
The GeneSight® Precision Medicine Test Drives Significant Medication Cost Savings in Patients with... Nov 04 2016
The GeneSight® Precision Medicine Test Drives Significant Medication Cost Savings in Patients with... Nov 04 2016
Myriad Posts 1Q Loss Vs Profit a Year Ago (MYGN) Nov 03 2016
MYRIAD GENETICS INC Files SEC form 10-Q, Quarterly Report Nov 02 2016
Myriad Genetics (MYGN) Earnings Miss, Revenues Top in Q1 Nov 02 2016
Edited Transcript of MYGN earnings conference call or presentation 1-Nov-16 8:30pm GMT Nov 01 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)